HSP47: a potential target for fibrotic diseases and implications for therapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

HSP47: a potential target for fibrotic diseases and implications for therapy

Published:2021-01-02 Issue:1 Volume:25 Page:49-62
ISSN:1472-8222
Container-title:Expert Opinion on Therapeutic Targets
language:en
Short-container-title:Expert Opinion on Therapeutic Targets

Author:

Bellaye Pierre-Simon¹²,Burgy Olivier²³,Bonniaud Philippe²,Kolb Martin⁴

Affiliation:

1. Centre George-Franrçois Leclerc, Nuclear Medicine department, Plateforme d’imagerie et de radiothérapie préclinique, 1 rue du professeur Marion, Dijon, France

2. Centre de Référence Constitutif des Maladies Pulmonaires Rares de l’Adultes de Dijon, Réseau OrphaLung, Filère RespiFil, Centre Hospitalier Universitaire de Bourgogne, Dijon,France

3. INSERM U1231 Department HSP-pathies 7 Boulevard Jeanne d’Arc,Dijon France

4. McMaster University, Department of medicine, FIRH, 50 Charlton Avenue East, Hamilton, Ontario, Canada

Funder

Investissements d’Avenir

Publisher

Informa UK Limited

Subject

Clinical Biochemistry,Drug Discovery,Pharmacology,Molecular Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14728222.2021.1861249

Reference97 articles.

1. Cellular and molecular mechanisms of fibrosis

2. Mechanisms of Fibrogenesis

3. Therapy for Fibrotic Diseases: Nearing the Starting Line

4. Fibrosis: ultimate and proximate causes

5. Structural and Functional Diversities between Members of the Human HSPB, HSPH, HSPA, and DNAJ Chaperone Families

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. HSP47 in human diseases: Navigating pathophysiology, diagnosis and therapy;Clinical and Translational Medicine;2024-08

2. The current landscape of antifibrotic therapy across different organs: A systematic approach;Pharmacological Research;2024-07

3. Targeting the HSP47-collagen axis inhibits brain metastasis by reversing M2 microglial polarization and restoring anti-tumor immunity;Cell Reports Medicine;2024-05

4. Targeting HSP47 for cancer treatment;Anti-Cancer Drugs;2024-04-29

5. Insights into the Mechanism of Action of the Degraded Limonoid Prieurianin;International Journal of Molecular Sciences;2024-03-22

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3